Trial Profile
A randomized double-blind study to determine the effect of GK activator (2) [RO 4389620] on efficacy (HbA1c), safety, tolerability and pharmacokinetics in patients with type 2 diabetes mellitus treated with a stable dose of metformin
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Sep 2021
Price :
$35
*
At a glance
- Drugs Piragliatin (Primary) ; Metformin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Roche
- 21 Sep 2007 Status changed from in progress to completed.
- 20 Oct 2006 Status change
- 06 Jun 2006 New trial record.